SPRING BANK TECHNOLOGIES, INC. AND MICROLOGIX BIOTECH, INC. STOCK PURCHASE AGREEMENT DECEMBER 17, 2003Stock Purchase Agreement • September 30th, 2004 • MIGENIX Inc. • Pharmaceutical preparations • Massachusetts
This Stock Purchase Agreement (the “Agreement”) is made as of the 17'h day of December 2003, by and between Spring Bank Technologies, Inc., a Massachusetts corporation having its principal office at 113 Cedar Street, Suite S7, Milford, MA 01757, USA (the Company”) and Micrologix Biotech, Inc., a British Columbia corporation having its offices at BC Research Complex, 3650 Wesbrook Mall, Vancouver, BC, Canada V6S 2L2 (“Micrologix”).
Stock PURCHASE AGREEMENTStock Purchase Agreement • September 30th, 2004 • MIGENIX Inc. • Pharmaceutical preparations • British Columbia
Pursuant to Section 4.1(b) of the Collaboration and License Agreement, the undersigned, Strata Pharmaceuticals Inc. (the "Subscriber"), hereby offers to subscribe for 617,284 Common Shares (the "Securities") of the Company, at a price of USD$0.81 per share, such Securities having the terms summarized below, upon and subject to the terms and conditions set forth on the reverse of this Stock Purchase Agreement (which terms and conditions are incorporated into and form part of this Stock Purchase Agreement) and delivers, with this subscription, the Total Subscription Price set forth below.
COLLABORATION AND LICENSE AGREEMENT between MICROLOGIX BIOTECH INC. and STRATA PHARMACEUTICALS INC. Dated: July 30, 2004Collaboration and License Agreement • September 30th, 2004 • MIGENIX Inc. • Pharmaceutical preparations • Delaware
This Collaboration and License Agreement (this "Agreement") is made as of July 30, 2004 (the "Effective Date") by and between Micrologix Biotech Inc., a British Columbia corporation having its offices at BC Research Complex, 3650 Wesbrook Mall, Vancouver, BC, Canada V6S 2L2 ("Micrologix") and Strata Pharmaceuticals Inc., a corporation having its offices at 10923 Coverhurst Way, San Diego, California 92130, USA ("Strata"). Micrologix and Strata are sometimes referred to collectively herein as the "Parties" or singly as a "Party".
ContractEscrow Agreement • September 30th, 2004 • MIGENIX Inc. • Pharmaceutical preparations • British Columbia
The Company has requested confidential treatment with respect to certain portions of this Agreement, which have been omitted, pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended
STOCK PURCHASE AGREEMENT BY AND BETWEEN VIROGEN LIMITED AND MICROLOGIX BIOTECH INC. February 20, 2004Stock Purchase Agreement • September 30th, 2004 • MIGENIX Inc. • Pharmaceutical preparations • British Columbia
WHEREAS pursuant to that certain celgosivir license agreement (the “License Agreement”) entered into by Virogen and Micrologix, dated as of February 2, 2004, Virogen agreed to grant a license to Micrologix and Micrologix agreed to obtain a license from Virogen to develop and commercialize certain program assets as more particularly described in the License Agreement;
LICENSE AGREEMENT BY AND BETWEEN MICROLOGIX BIOTECH INC. AND SPRING BANK TECHNOLOGIES, INC. DATED: December 8, 2003License Agreement • September 30th, 2004 • MIGENIX Inc. • Pharmaceutical preparations • New York
MICROLOGIX BIOTECH INC., a British Columbia corporation having its offices at BC Research Complex, 3650 Wesbrook Mall, Vancouver, BC, Canada V6S 2L2
ContractAgreement and Plan of Merger and Reorganization • September 30th, 2004 • MIGENIX Inc. • Pharmaceutical preparations • California
The Company has requested confidential treatment with respect to certain portions of this Agreement, which have been omitted, pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended
ContractCelgosivir License Agreement • September 30th, 2004 • MIGENIX Inc. • Pharmaceutical preparations • Delaware
The Company has requested confidential treatment with respect to certain portions of this Agreement, which have been omitted, pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.
